Pomerantz Investigating Nutex Health Securities Fraud Claims

Pomerantz LLP is investigating claims of securities fraud against Nutex Health Inc. (NASDAQ: NUTX) on behalf of investors. The investigation concerns allegations by Blue Orca Capital that Nutex faces litigation risk due to its relationship with a third-party vendor, HaloMD, which was sued for engaging in a fraudulent scheme to take millions from insurance companies. Following publication of the Blue Orca report, Nutex's stock price fell 10.05% to $100.01 per share. Investors who have held Nutex stock are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Pomerantz LLP has initiated an investigation into claims of securities fraud against Nutex Health Inc. (NASDAQ: NUTX) on behalf of investors. The investigation centers around allegations made by Blue Orca Capital that Nutex faces litigation risk due to its relationship with HaloMD, a third-party vendor recently sued for engaging in a fraudulent scheme to take millions from insurance companies. Following the publication of the Blue Orca report, Nutex's stock price fell by 10.05%, closing at $100.01 per share on July 22, 2025 [2].

The Blue Orca report alleges that Nutex's involvement with HaloMD, a billing consulting company led by former Las Vegas stripper and Apprentice contestant Alla Laroque, has put the company at risk. Three recent lawsuits accuse HaloMD of theft, fraud, and racketeering, claiming that the company flooded the system with ineligible arbitration claims at inflated rates. Although Nutex was not named in these lawsuits, Blue Orca warns that Nutex may be targeted in future litigation [3].

Pomerantz LLP, a premier firm in corporate, securities, and antitrust class litigation, is encouraging investors who have held Nutex stock to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices [2].

Investors who have suffered substantial losses or have knowledge that may assist the firm's investigation are advised to submit their losses or contact Danielle Peyton for more information.

References:
[1] https://www.globenewswire.com/news-release/2025/08/12/3132236/0/en/NUTEX-NUTX-INVESTIGATION-ALERT-Bragar-Eagel-Squire-P-C-is-Investigating-Nutex-Health-Inc-on-Behalf-of-Nutex-Stockholders-and-Encourages-Investors-to-Contact-the-Firm.html
[2] https://www.prnewswire.com/news-releases/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-nutex-health-inc---nutx-302525750.html
[3] https://www.morningstar.com/news/globe-newswire/9511107/nutex-health-nutx-shares-fall-amid-critical-blue-orca-report-hagens-berman